Skip navigation

Repositorio Institucional Continental

Please use this identifier to cite or link to this item:
Title: Immune Thrombocytopenic Purpura and Gastritis by H. pylori Associated With Type 1 Diabetes Mellitus
Authors: Culquichicon-Sanchez, Carlos
Correa, Ricardo
Flores-Guevara, Igor
Espinoza Morales, Frank
Mejia, Christian R.
Keywords: Diabetes
Enfermedades gastrointestinales
América Latina
Publisher: Universidad Continental
Issue Date: Feb-2016
Date available: 8-Jul-2020
Creation date: 2016
Bibliographic citation: Culquichicon, C, Correa, R., Flores, I., Morales, F., Mejia, C. (2016). Immune Thrombocytopenic Purpura and Gastritis by H. pylori Associated With Type 1 Diabetes Mellitus. Cureus, 8(2). 10.7759/cureus.512
DOI: 10.7759/cureus.512
Abstract: We present the 15th case reported worldwide and 3rd case reported in Latin America of immune thrombocytopenic purpura associated with Type 1 diabetes mellitus in Scopus, MEDLINE, and SciELO. An 11-year-old male patient of mixed ethnicity with immune thrombocytopenic purpura, Type 1 diabetes mellitus, and gastritis due to H. pylori presented to the emergency room with petechiae, ecchymosis, and gingival and conjunctival bleeding that had been worsening for the past three months. The patient had a body mass index of 18.85 kg/m2 (P75). A biochemical analysis showed 1×109 platelets/L, increased prothrombin time, increased partial thromboplastin time, and an HbA1C of 7.84% on admission. He was prescribed a single dose of intravenous methylprednisolone 750 mg in 100 mL of NaCl and daily oral 50 mg prednisolone, with intravenous 250 mg tranexamic acid every eight hours. The patient’s glycemic control was continued with the administration of insulin glargine (30 units every 24 hours) and prandial insulin glulisine (five to eight units per meal). Before admission, the patient was on a prescribed treatment of sitagliptin 50 mg and metformin 850 mg, but this was suspended in the emergency room. For the eradication of H. pylori he was prescribed amoxicillin 500 mg every eight hours, oral clarithromycin 335 mg every 12 hours, and IV omeprazole 40 mg. After 15 days, he showed disease resolution and he was discharged to his home with orders to follow-up with pediatrics, hematology, and endocrinology services. The first-line treatment for immune thrombocytopenic purpura patients with active bleeding and a platelet count < 30,000 platelets/μl is the administration of corticosteroids and inmunoglobulin.
Included in:
metadata.dc.format.extent: 4 páginas
Access: Acceso abierto
Source: Universidad Continental
Repositorio Institucional - Continental
Appears in Collections:Artículos Científicos

Files in This Item:
There are no files associated with this item.
Show full item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.